Literature DB >> 12003995

Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.

Luigi Tornillo1, Vincenza Carafa, Guido Sauter, Holger Moch, Ernesto Minola, Marcello Gambacorta, Raffaela Vecchione, Leonardo Bianchi, Luigi M Terracciano.   

Abstract

Data from experimental hepatocarcinogenesis and recent studies in humans have suggested that the emergence of hepatocellular carcinoma (HCC) is a stepwise process. However, despite abundant experimental data, the precise molecular mechanisms and genetic alterations involved in human liver carcinogenesis are still unclear. Comparative genomic hybridization was used to analyze 26 hepatocellular nodules obtained from patients undergoing liver transplantation or surgical resection for HCC. According to the criteria proposed by the International Working Party, 16 nodules were classified as multiacinar regenerative nodules (MRN), 4 as low-grade dysplastic nodules (LG-DN), and 6 as high-grade dysplastic nodules (HG-DN). Our aim was to investigate the possible genetic differences between MRN, LG-DN, and HG-DN. The whole group of nodules showed only a few aberrations (mean 1.1/case), without any significant pattern. This finding is comparable to what happens in non-neoplastic tissue. On the contrary, in three of six HG-DN, we found deletions of 8p and gains of 1q. LG-DN and MRN did not show these chromosomal imbalances. These results confirm the important role of allelic losses on 8p as well as of gains of 1q in HCC. We conclude that the genes that are important in early stages of hepatocarcinogenesis are probably located on these chromosomal arms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003995     DOI: 10.1038/labinvest.3780449

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  6 in total

1.  Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.

Authors:  Ryan A Hlady; Dan Zhou; William Puszyk; Lewis R Roberts; Chen Liu; Keith D Robertson
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

Review 2.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 3.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

Review 4.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

5.  Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.

Authors:  Ryan A Hlady; Xia Zhao; Xiaoyu Pan; Ju Dong Yang; Fowsiyo Ahmed; Samuel O Antwi; Nasra H Giama; Tushar Patel; Lewis R Roberts; Chen Liu; Keith D Robertson
Journal:  Theranostics       Date:  2019-09-25       Impact factor: 11.556

6.  Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.

Authors:  Francesca Rizzo; Antonio Rinaldi; Giovanna Marchese; Elena Coviello; Assunta Sellitto; Angela Cordella; Giorgio Giurato; Giovanni Nassa; Maria Ravo; Roberta Tarallo; Luciano Milanesi; Anna Destro; Guido Torzilli; Massimo Roncalli; Luca Di Tommaso; Alessandro Weisz
Journal:  Oncotarget       Date:  2016-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.